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We read with interest the review in CMI by Pastor
and Guarro [1] concerning the clinical manifesta-
tions, treatment and outcome of Paecilomyces
lilacinus infections. We entirely agree with the
authors that P. lilacinus can cause a devastating
oculomycosis. However, we would like to draw
the attention of readers to three errors in their
report of our own case [2]. This case involved a
patient in whom P. lilacinus caused endophthalm-
itis following metastatic spread of the organism
via the bloodstream. The patient was not immu-
nosuppressed, but had developed anterior uveitis
following severe systemic upset secondary to
diarrhoea immediately before the onset of eye
symptoms. This blood-borne spread of infection
then progressed to a clinical picture of endoph-
thalmitis. Not only was the case unusual in this
respect, but it is also the only case, to date, that
has demonstrated that this organism can cause a
secondary keratitis from within the eye. It is also
erroneous to state that the ‘outcome’ of the case
was ‘recovery’, when after 2 years the vision was
only ‘count fingers’ (with an opaque corneal
graft).
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